DO TYPICAL CLINICAL DOSES OF METHYLPHENIDATE CAUSE TICS IN CHILDREN TREATED FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER?
I tiakina i:
LAW, S.F., SCHACHAR, R.J., DO TYPICAL CLINICAL DOSES OF METHYLPHENIDATE CAUSE TICS IN CHILDREN TREATED FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER?. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, Vol. 38, no. 8 (1999), p. 944-951.
Ref.
81833
Tauwāhi:
SIIS SIIS Madrid R. 598
Palabras clave:
Efectos, Efectos no deseados, Enfermedades mentales, Fármacos, Hiperactividad, Infancia, Trastornos de atención
Efectos, Efectos no deseados, Enfermedades mentales, Fármacos, Hiperactividad, Infancia, Trastornos de atención
Ngā tūemi rite: DO TYPICAL CLINICAL DOSES OF METHYLPHENIDATE CAUSE TICS IN CHILDREN TREATED FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER?
- ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY AND METHYLPHENIDATE: THE EFFECTS OF DOSE AND MASTERY LEVEL ON CHILDREN'S LEARNING PERFORMANCE
- METHYLPHENIDATE AND COGNITIVE FLEXIBILITY: DISSOCIATED DOSE EFFECTS IN HYPERACTIVE CHILDREN
- BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- DIFFERENTIAL EFFECTIVENESS OF METHYLPHENIDATE AND ADDERALL IN SCHOOL-AGE YOUTHS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- PREDICTION OF CLINICAL RESPONSE TO METHYLPHENIDATE IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- Efficacy and safety of methylphenidate on attention deficit hyperactivity disorder in children with Down syndrome